<i>GPX3</i> Hypermethylation in Gastric Cancer and its Prognostic Value in Patients Aged Over 60

Cong Zhou(Hunan Agricultural University), Shiwei Duan(Communication University of Zhejiang), Tianyi Huang(Brigham and Women's Hospital), Jieer Ying(Chinese Academy of Medical Sciences & Peking Union Medical College), Bin Li(State Key Laboratory of Respiratory Disease), Jun Zhao(United States Food and Drug Administration), Ranran Pan(Ningbo University)
Future Oncology
March 29, 2019
10.2217/fon-2018-0674
Cited by 34

Related Papers

Targeting PI3K/Akt signal transduction for cancer therapy
|Signal Transduction and Targeted Therapy|2021|1.7k
Hepatogastroenterology
|Hepatogastroenterology|2012|1.3k
Advances in targeted therapy for esophageal cancer
|Signal Transduction and Targeted Therapy|2020|546
Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial
|Journal of Clinical Oncology|2021|417
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023
|癌症：英文版|2023|412